COMPANY

ElSohly Laboratories, Incorporated

HQ: Oxford, MS source · elsohly.com ↗ · Southeast

FDA-cleared device company

Location: Oxford, MS · source · Oct 15, 2026

Profile checked Oct 10, 2026

26NIH grants

Timeline

Apr 15, 2025 Grant Government grant — NIH R21: $228,967 (annual award, as published), announced Apr 15, 2025. Agency: NIH/NIDA. Source: government award database. source ↗

Funding

Last 2 years.

Apr 15, 2025 Government grant — NIH R21: $228,967 (annual award, as published), announced Apr 15, 2025. Agency: NIH/NIDA. Source: government award database. source ↗

NIH awards 26

Annual award amounts. Total $4.9M.

Apr 12, 2024 NIH award 1R21DA060394-01 FY2024: $198,912 awarded for that fiscal year; activity R21 (OTHER_NIH); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Isolation and Pharmacological Ev source ↗
Feb 13, 2019 NIH award 1R41DA047802-01A1 FY2019: $182,361 awarded for that fiscal year; activity R41 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Development of a Process for GMP Pr source ↗
Jun 25, 2018 NIH award 1R41DA047186-01 FY2018: $180,830 awarded for that fiscal year; activity R41 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. An Opioid/Cannabinoid Analgesic that source ↗
Aug 2, 2013 NIH award 1R41AI108113-01 FY2013: $205,514 awarded for that fiscal year; activity R41 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Orally Active Formulations of DHA Dim source ↗
Feb 14, 2011 NIH award 1R41EY020042-01A1 FY2011: $167,381 awarded for that fiscal year; activity R41 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Development of Tetrahydrocannabinol source ↗
Sep 27, 2010 NIH award 3R42GM067304-03S1 FY2010: $213,604 awarded for that fiscal year; activity R42 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Transmucosal Intra-Oral Drug Delive source ↗
Aug 4, 2010 NIH award 5R42AR053395-03 FY2010: $366,814 awarded for that fiscal year; activity R42 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Compositions for Prevention/Prophylac source ↗
Sep 8, 2009 NIH award 2R42AR053395-02A1 FY2009: $372,404 awarded for that fiscal year; activity R42 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Compositions for Prevention/Prophyl source ↗
Jun 3, 2009 NIH award 5R42GM067304-03 FY2009: $398,915 awarded for that fiscal year; activity R42 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Transmucosal Intra-Oral Drug Delivery source ↗
May 30, 2008 NIH award 2R42GM067304-02 FY2008: $344,694 awarded for that fiscal year; activity R42 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Transmucosal Intra-Oral Drug Delivery source ↗
Aug 11, 2006 NIH award 1R41AR053395-01 FY2006: $100,074 awarded for that fiscal year; activity R41 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Compositions for Prevention/Prophylac source ↗
Aug 25, 2003 NIH award 1R41GM067304-01 FY2003: $99,986 awarded for that fiscal year; activity R41 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Transmucosal Intra-Oral Drug Delivery source ↗
Apr 30, 2002 NIH award 1R43DA014460-01A1 FY2002: $93,816 awarded for that fiscal year; activity R43 (SBIR); PI FENG, SHIXIA; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. Synthesis of Conjugated Metabolites of Bup source ↗
Aug 17, 2001 NIH award 5R42AI042406-03 FY2001: $68,500 awarded for that fiscal year; activity R42 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. PRECLINICAL DEVELOP. OF A NEW DRUG FOR source ↗
Sep 13, 2000 NIH award 2R42AI042406-02 FY2000: $276,333 awarded for that fiscal year; activity R42 (STTR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. DEVELOPMENT OF A NEW DRUG FOR P. CARI source ↗
2000 NIH contract (government contract; not a grant and not an investment round) N44DA007064-000 FY2000: $682,137 awarded for that fiscal year; activity N44 (OTHER_NIH); PI ELSOHLY, MAMOUD; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. DEVELO[ AN EC source ↗
2000 NIH contract (government contract; not a grant and not an investment round) N43DA097064-1-0-0 FY2000: activity N43 (OTHER_NIH); PI ELSOHLY, M A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. DEVELOPMENT OF AN ECONOMIC SUPPLY OF DELTA-9-THC source ↗
1999 NIH contract (government contract; not a grant and not an investment round) N43DA097064-000 FY1999: $97,353 awarded for that fiscal year; activity N43 (OTHER_NIH); PI ELSOHLY, M A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. DEVELOPMENT OF AN source ↗
Apr 24, 1998 NIH award 1R41AI042406-01A1 FY1998: $99,886 awarded for that fiscal year; activity R41 (STTR); PI CLARK, ALICE M.; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. PRECLINICAL DEVELOPMENT OF A NEW DRUG F source ↗
1998 NIH contract (government contract; not a grant and not an investment round) N44DA077057-001 FY1998: n/a awarded for that fiscal year; activity N44 (OTHER_NIH); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. IDENTIFICATION source ↗
1997 NIH contract (government contract; not a grant and not an investment round) N44DA077057-000 FY1997: $315,780 awarded for that fiscal year; activity N44 (OTHER_NIH); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. IDENTIFICA source ↗
1996 NIH contract (government contract; not a grant and not an investment round) N43DA067057-000 FY1996: $100,000 awarded for that fiscal year; activity N43 (OTHER_NIH); PI ELSOHLY, MAHMOUD; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. IDENTIFY/ANA source ↗
Aug 31, 1989 NIH award 5R44DA004469-03 FY1989: $121,547 awarded for that fiscal year; activity R44 (SBIR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. DEVELOPMENT OF A NEW FORMULATION FOR source ↗
Sep 22, 1988 NIH award 2R44DA004469-02 FY1988: $151,960 awarded for that fiscal year; activity R44 (SBIR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. DEVELOPMENT OF A NEW FORMULATION FOR source ↗
Sep 29, 1987 NIH award 1R43DA005398-01 FY1987: $48,128 awarded for that fiscal year; activity R43 (SBIR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. DEVELOPMENT OF A CANNABIS FINGERPRINT source ↗
1986 NIH award 1R43DA004469-01 FY1986: $42,884 awarded for that fiscal year; activity R43 (SBIR); PI ELSOHLY, MAHMOUD A; recipient as written: ELSOHLY LABORATORIES, INC., OXFORD, MS. DEV OF NEW FORMULATION FOR STUDIES OF source ↗